Ambar Protein Industries , a leading manufacturer and seller of edible oil, has announced its unaudited financial results for the first quarter ended June 30, 2025, along with key corporate updates.

Financial Performance

The company reported a mixed financial performance for Q1 FY2026:

Despite a significant increase in revenue, Ambar Protein Industries experienced a decline in profitability compared to the same quarter last year. The company's revenue from operations grew by 26.51% year-over-year to ₹11771.19 lacs, while total income rose by 25.95% to ₹11746.31 lacs. However, net profit for the quarter decreased by 56.69% to ₹74.63 lacs, compared to ₹172.30 lacs in Q1 FY2025.

Corporate Updates

The Board of Directors, in their meeting held on August 14, 2025, approved several key matters:

1. 32nd Annual General Meeting: The notice for the 32nd AGM, scheduled for September 30, 2025, at 10:00 A.M., was approved. The meeting will be held at the company's registered office in Ahmedabad.

2. Book Closure: The Register of Members and Share Transfer Books will be closed from September 20, 2025, to September 30, 2025 (both days inclusive) for the purpose of the AGM.

3. E-voting Facility: The company has arranged e-voting facilities through CDSL, with remote e-voting commencing on September 27, 2025, at 9:00 A.M. and concluding on September 29, 2025, at 5:00 P.M.

4. Board of Directors Report: The Board approved the Directors' Report for the year ended March 31, 2025.

Changes in Independent Directors

Ambar Protein Industries also announced the completion of tenure for three Independent Directors as of August 14, 2025:

1. Mr. Pradipkumar Sevantilal Shah
2. Mr. Parimalbhai Bhailalbhai Shah
3. Mr. Meghalkumar Harishbhai Chakravarti

The company expressed its appreciation for the valuable contributions and guidance provided by these directors during their association with Ambar Protein Industries.

Business Segment

Ambar Protein Industries continues to operate in a single business segment, focusing on the manufacturing and selling of edible oil.

Ambar Protein Industries (formerly Ankur Protein Industries Ltd) has announced significant changes to its board of directors, appointing three new Additional Non-Executive Independent Directors and a new Chairman, effective August 6, 2025, subject to shareholder approval.

New Appointments and Roles

Chairman and Independent Director

Mr. Gangaram Bhanjibhai Patel (DIN: 03542769) has been appointed as the new Chairman and Independent Director of the company. With over 30 years of expertise in GST Audit, Income Tax Audit, and financial consultancy, Mr. Patel brings a wealth of experience to the role. As a Chartered Accountant, he is expected to contribute significantly to the company's financial strategy and governance.

Independent Directors

• Mr. Yogen Pranjivandas Patel (DIN: 11187981): Holding a D.D.S. from L.L.U California, USA, Mr. Patel specializes in planning and development, public policy, public finance, and public-private partnerships. His diverse background also includes expertise in mines and geology, official statistics, medical statistics, and general administration.

• Mr. Narottam Chaturdas Tanna (DIN: 03542769): A commerce graduate with over 35 years of experience in the Edible Oil business, Mr. Tanna's extensive industry knowledge is expected to provide valuable insights to the company's operations.

Terms of Appointment

All three appointments are for five-year terms, from August 6, 2025, to August 5, 2030, pending shareholder approval at the upcoming Annual General Meeting.

Board Restructuring

As part of this major board reshuffle, the company has removed Shri Pradeep S Shah from the Chairmanship. Additionally, Ambar Protein Industries has reconstituted its key committees:

1. Audit Committee
2. Nomination and Remuneration Committee
3. Corporate Social Responsibility Committee
4. Stakeholders Relationship Committee

The newly appointed directors will play crucial roles in these committees, ensuring fresh perspectives and robust governance.

Independence and Compliance

The company has confirmed that none of the new directors are related to existing board members. Furthermore, they are not debarred from holding directorial positions by any SEBI order or other regulatory authority, ensuring compliance with corporate governance norms.

This board restructuring marks a significant step for Ambar Protein Industries, potentially bringing new strategic directions and strengthened corporate governance to the company. Shareholders and market watchers will be keenly observing how these changes impact the company's future performance and decision-making processes.